Copyright
©2013 Baishideng Publishing Group Co.
World J Gastrointest Oncol. Apr 15, 2013; 5(4): 81-87
Published online Apr 15, 2013. doi: 10.4251/wjgo.v5.i4.81
Published online Apr 15, 2013. doi: 10.4251/wjgo.v5.i4.81
Table 2 Tumor data of 263 resectable cholangiocarcinoma n (%)
| Tumor location | |
| Intrahepatic | 166 (63.1) |
| Perihilar | 91 (34.6) |
| Distal | 6 (2.3) |
| AJCC staging | |
| 0 | 11 (4.2) |
| 1 | 37 (14.1) |
| 2 | 54 (20.5) |
| 3 | 89 (33.8) |
| 4 | 72 (27.4) |
| pT stage | |
| 0 | 10 (3.8) |
| 1 | 47 (17.9) |
| 2 | 85 (32.3) |
| 3 | 95 (36.1) |
| 4 | 25 (9.5) |
| pN stage | |
| 0 | 167 (63.5) |
| 1 | 96 (36.5) |
| Tumor grading | |
| Well diff | 198 (75.3) |
| Moderate diff | 14 (5.3) |
| Not available | 51 (19.4) |
| Margin surgical resection | |
| Free | 134 (51.0) |
| Not free | 129 (49.0) |
- Citation: Wirasorn K, Ngamprasertchai T, Chindaprasirt J, Sookprasert A, Khantikaew N, Pakkhem A, Ungarereevittaya P. Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy. World J Gastrointest Oncol 2013; 5(4): 81-87
- URL: https://www.wjgnet.com/1948-5204/full/v5/i4/81.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v5.i4.81